AAAAAA

   
Results: 1-9 |
Results: 9
Homozygous thermolabile variant of the methylenetetrahydrofolate reductasegene: a potential risk factor for hyperhomocysteinaemia, CVD, and stroke in childhood
Authors: Prengler, M Sturt, N Krywawych, S Surtees, R Liesner, R Kirkham, F
Citation: M. Prengler et al., Homozygous thermolabile variant of the methylenetetrahydrofolate reductasegene: a potential risk factor for hyperhomocysteinaemia, CVD, and stroke in childhood, DEVELOP MED, 43(4), 2001, pp. 220-225
Mutations in the ELA2 gene encoding neutrophil elastase are present in most patients with sporadic severe congenital neutropenia but only in some patients with the familial form of the disease
Authors: Ancliff, PJ Gale, RE Liesner, R Hann, IM Linch, DC
Citation: Pj. Ancliff et al., Mutations in the ELA2 gene encoding neutrophil elastase are present in most patients with sporadic severe congenital neutropenia but only in some patients with the familial form of the disease, BLOOD, 98(9), 2001, pp. 2645-2650
Severe factor V deficiency and neonatal intracranial haemorrhage: a case report
Authors: Salooja, N Martin, P Khair, K Liesner, R Hann, I
Citation: N. Salooja et al., Severe factor V deficiency and neonatal intracranial haemorrhage: a case report, HAEMOPHILIA, 6(1), 2000, pp. 44-46
Hermansky-Pudlak syndrome presenting with subdural haematoma and retinal haemorrhages in infancy
Authors: Russell-Eggitt, IM Thompson, DA Khair, K Liesner, R Hann, IM
Citation: Im. Russell-eggitt et al., Hermansky-Pudlak syndrome presenting with subdural haematoma and retinal haemorrhages in infancy, J ROY S MED, 93(11), 2000, pp. 591-592
von Willebrand factor-cleaving protease activity in congenital thrombotic thrombocytopenic purpura
Authors: Allford, SL Harrison, P Lawrie, AS Liesner, R Mackie, IJ Machin, SJ
Citation: Sl. Allford et al., von Willebrand factor-cleaving protease activity in congenital thrombotic thrombocytopenic purpura, BR J HAEM, 111(4), 2000, pp. 1215-1222
Central venous access devices in children with congenital coagulation disorders: complications and long-term outcome
Authors: McMahon, C Smith, J Khair, K Liesner, R Hann, IM Smith, OP
Citation: C. Mcmahon et al., Central venous access devices in children with congenital coagulation disorders: complications and long-term outcome, BR J HAEM, 110(2), 2000, pp. 461-468
The use of recombinant factor VIIa in a patient with severe Glanzmann's thrombasthenia to facilitate insertion of a Port-a-Cath (R)
Authors: Ancliff, P Liesner, R Khair, K Hann, I
Citation: P. Ancliff et al., The use of recombinant factor VIIa in a patient with severe Glanzmann's thrombasthenia to facilitate insertion of a Port-a-Cath (R), BL COAG FIB, 10(7), 1999, pp. 447-448
Performance of the platelet function analyser PFA-100 (R) in testing abnormalities of primary haemostasis
Authors: Harrison, P Robinson, MSC Mackie, IJ Joseph, J McDonald, SJ Liesner, R Savidge, GF Pasi, J Machin, SJ
Citation: P. Harrison et al., Performance of the platelet function analyser PFA-100 (R) in testing abnormalities of primary haemostasis, BL COAG FIB, 10(1), 1999, pp. 25-31
Prothrombotic changes in children with sickle cell disease: relationships to cerebrovascular disease and transfusion
Authors: Liesner, R Mackie, I Cookson, J McDonald, S Chitolie, A Donohoe, S Evans, J Hann, I Machin, S
Citation: R. Liesner et al., Prothrombotic changes in children with sickle cell disease: relationships to cerebrovascular disease and transfusion, BR J HAEM, 103(4), 1998, pp. 1037-1044
Risultati: 1-9 |